Xlife Sciences AG 13D and 13G filings for Veraxa Biotech AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-15 3:46 pm Purchase | 2026-06-10 | 13D | VERAXA BIOTECH HLDG AG WT EXP VRXAW | Xlife Sciences AG | 23,029,967 16.300% | 23,029,967 (New Position) | Filing |